Sanity Group: Europe's leading cannabis company

Vayamed and telemedicine pioneer Telaleaf launch exclusive partnership

February 8, 2022

German medical cannabis specialist Vayamed and the telemedicine platform Telaleaf agreed on an exclusive partnership to strengthen telemedicine in cannabis therapy in Germany. The focus will be on therapy quality, patient centered pricing, individual therapy plans, and equitable therapy access. Telaleaf is a pioneer in cannabis-based telemedicine from Canada established in 2020 and will now launch its services in the German healthcare system.

Endosane and UCI investigate the efficacy of new compounds for the treatment of PTSD

January 18, 2022

Endosane Pharmaceuticals and the University of California Irvine (UCI) have agreed to investigate the efficacy of two innovative compounds for the treatment of post-traumatic stress disorder (PTSD) through a series of preclinical studies. The studies will be conducted in the laboratory of the internationally renowned neuropharmacologist and leading endocannabinoid system researcher, Professor Daniele Piomelli. Results are expected as early as the first half of 2022.

Sanity Group appreciates the controlled dispensing of cannabis as stated in the coalition agreement

November 24, 2021

In their coalition agreement presented today, the parties SPD, Bündnis 90/Die Grünen and FDP have spoken out favouring controlled dispensing of cannabis. They would like to legalise the sale of cannabis for consumption purposes. Berlin-based cannabis company Sanity Group appreciated the decision.

Unlocking the health benefits of cannabinoids.

We are a team of medical experts.

Medical Advisory Board

Political Advisory Board

Latest News

Vayamed and telemedicine pioneer Telaleaf launch exclusive partnership

Endosane and UCI investigate the efficacy of new compounds for the treatment of PTSD

Sanity Group appreciates the controlled dispensing of cannabis as stated in the coalition agreement

Who We Are

Our Brands

Press Area

Contact